Dan Deaton

Dan Deaton Email and Phone Number

Head of Inhaled Product Development at AstraZeneca @ AstraZeneca
Dan Deaton's Location
Raleigh-Durham-Chapel Hill Area, United States, United States
Dan Deaton's Contact Details

Dan Deaton personal email

Dan Deaton phone numbers

About Dan Deaton

Accomplished senior executive with 25+ years of experience in the pharmaceutical and medical device industries. Dedicated to improving patients' lives and experiences through the development and commercialization of innovative therapies and advanced delivery systems. Proven expertise in leading high-performing, agile teams to drive focused execution and accelerate delivery of novel combination drug products, delivery devices, and digital health technologies.Key Areas of Expertise:- Inhaled drug development, including clinical supply, global regulatory filings, and commercialization- Strategic development and portfolio management for pharmaceutical products and device technologies- Navigation of complex global regulatory and intellectual property (IP) landscapes- Innovation and portfolio processes to meet evolving needs for new technologies and new drug modalities to serve changing patient populations- Competitive analysis and business case development- Due diligence for new product and technology opportunities- Organizational and operational management and leadershipStrengths:- Building and leading high-performing teams with a focus on positive, energetic, and collaborative work cultures and external partnerships- Combining strong engineering and technical aptitudes with a deep appreciation for strategic business objectives- Technical expertise as a mechanical designer and inventor, developing a wide range of patient focused proprietary products including drug delivery devices, medical equipment and digital health solutions.- Track record of successful end-to-end development and commercialization of drug products and technologies focused on improving patient outcomes.

Dan Deaton's Current Company Details
AstraZeneca

Astrazeneca

View
Head of Inhaled Product Development at AstraZeneca
Dan Deaton Work Experience Details
  • Astrazeneca
    Head Of Inhaled Product Development (Interim)
    Astrazeneca Apr 2024 - Present
    Cambridge, Cambridgeshire, Gb
  • Astrazeneca
    Executive Director Patient Experience And Innovation
    Astrazeneca Nov 2022 - Mar 2024
    Cambridge, Cambridgeshire, Gb
  • Astrazeneca
    Senior Director Device Development
    Astrazeneca Apr 2017 - Nov 2022
    Cambridge, Cambridgeshire, Gb
  • Triangle Angel Partners (Tap)
    Angel Investor
    Triangle Angel Partners (Tap) Sep 2011 - Present
    Triangle Angel Partners is an experienced band of angel investors in the high tech and life sciences industries, interested in investing their time, analysis and money into early life cycle companies.
  • Community Workforce Solutions
    Board Of Directors
    Community Workforce Solutions Jan 2012 - Jun 2023
    Raleigh, North Carolina, Us
    Community Workforce Solutions, Inc. is dedicated to supporting persons with disabilities and other barriers to employment as each individual works to achieve his/her individually chosen employment and community integration goals.
  • Polarean, Inc.
    Board Director
    Polarean, Inc. Oct 2011 - May 2017
    Durham, Nc, Us
    Polarean designs and manufactures equipment for production of hyperpolarized xenon or helium gas. When used in conjunction with MRI, these gases offer a fundamentally new and non-invasive functional imaging platform. Current investigational uses include identifying early diagnoses of respiratory diseases as well as monitoring progression and therapeutic response. In addition, xenon gas exhibits solubility and signal properties that enable it to be imaged within other tissues and organs. Polarean hyperpolarization systems are currently sold in the United States and internationally for research and investigational applications only.
  • Grayscope Development
    Managing Director
    Grayscope Development Nov 2013 - Apr 2017
    We provide expertise, drive, and ingenuity to develop best in class healthcare products. We partner with clients ranging from new ventures to Fortune 500 companies who are seeking to respond to fast paced competition with precision and energy. Current areas of focus include connected healthcare and next generation drug delivery devices.
  • Ibiliti
    Vice President Of Innovation
    Ibiliti Jan 2011 - Jan 2014
    Exclusively focused on North Carolina’s medical technology industry, ibiliti was a non-profit organization committed to assisting novel medical ideas reach market at optimal speed and minimal cost. In 2014, the organization was acquired by the North Carolina Hospital Association to work closely with member health systems to identify, develop and launch transformational innovations that benefit patients.
  • Oriel Therapeutics (A Sandoz/Novartis Company)
    Director Of Product Development
    Oriel Therapeutics (A Sandoz/Novartis Company) Oct 2007 - Dec 2010
    Us
    Venture funded specialty pharmaceutical specializing in commercialization of generic respiratory drug products based on proprietary dry powder inhalers. Oriel Therapeutics was acquired by Sandoz, the generic arm of Novartis in May 2010.
  • Kos Pharmaceuticals
    Associate Director Biomedical Engineering
    Kos Pharmaceuticals 2001 - 2007
    Us
    A fully integrated specialty pharmaceutical specializing in cardiovascular and respiratory disease - the 6th fastest growing company in the US (Fortune Sep2005). Acquired by Abbott in 2006 for $3.7 Billion.

Dan Deaton Skills

Medical Devices Commercialization Product Development Cross Functional Team Leadership Strategy Strategic Planning Start Ups Business Development Product Launch R&d Venture Capital Entrepreneurship Pharmaceutical Industry Project Management Global Marketing Fda Technology Transfer Biomedical Engineering Strategic Partnerships Competitive Analysis Research And Development Management Angel Investing

Dan Deaton Education Details

  • North Carolina State University
    North Carolina State University
    Mechanical Engineering
  • Unc Kenan-Flagler Business School
    Unc Kenan-Flagler Business School
    Mba
  • North Carolina State University
    North Carolina State University
    Mechanical Engineering

Frequently Asked Questions about Dan Deaton

What company does Dan Deaton work for?

Dan Deaton works for Astrazeneca

What is Dan Deaton's role at the current company?

Dan Deaton's current role is Head of Inhaled Product Development at AstraZeneca.

What is Dan Deaton's email address?

Dan Deaton's email address is dm****@****ail.com

What is Dan Deaton's direct phone number?

Dan Deaton's direct phone number is +971 4 362*****

What schools did Dan Deaton attend?

Dan Deaton attended North Carolina State University, Unc Kenan-Flagler Business School, North Carolina State University.

What skills is Dan Deaton known for?

Dan Deaton has skills like Medical Devices, Commercialization, Product Development, Cross Functional Team Leadership, Strategy, Strategic Planning, Start Ups, Business Development, Product Launch, R&d, Venture Capital, Entrepreneurship.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.